At ELSO, a new oxygenation approach
Dr. Tobias Straube presented the technology and physiology behind VQ’s catheter at the 36th Annual ELSO Conference.
Follow the
work forward.
Company updates, scientific conversations and development milestones.
Read original
MedTech Innovator: recognition for the work ahead
VQ joined the 2025 cohort and was named a finalist for the Value and Execution awards.
A milestone for device development
The company announced $5 million in total capital, including a $1.65 million seed round and non-dilutive support.
Updates are dated as originally published. Follow the linked company and institutional sources for current details.